推荐产品
生物来源
mouse
质量水平
抗体形式
purified immunoglobulin
抗体产品类型
primary antibodies
克隆
542-7D, monoclonal
种属反应性
human
制造商/商品名称
Chemicon®
技术
immunofluorescence: suitable
同位素/亚型
IgG
运输
wet ice
特异性
冠状病毒核蛋白；OC-43株
免疫原
表位：OC-43的核蛋白。
应用
IFA。 最终工作稀释度必须由最终用户确定。
抗冠状病毒组抗原抗体，OC-43核蛋白，克隆542-7D检测冠状病毒组抗原的水平，&已发布&验证可用于IF。
研究子类别
传染病 - 病毒
传染病 - 病毒
研究类别
传染病
传染病
外形
形式：纯化
纯化免疫球蛋白。提供在pH 7.4的PBS缓冲液中。含0.1%叠氮化钠和载体蛋白。
储存及稳定性
在+4°C下保存长达12个月。 应避免反复冻/融循环。
法律信息
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
免责声明
除非我们的目录或产品随附的其他公司文件中另有说明，否则我们的产品预期仅用于研究用途，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。
未找到合适的产品？
试试我们的产品选型工具.
储存分类代码
12 - Non Combustible Liquids
WGK
WGK 2
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
常规特殊物品
Gergely Rona et al.
Cell death and differentiation, 29(2), 285-292 (2021-12-05)
The risk of zoonotic coronavirus spillover into the human population, as highlighted by the SARS-CoV-2 pandemic, demands the development of pan-coronavirus antivirals. The efficacy of existing antiviral ribonucleoside/ribonucleotide analogs, such as remdesivir, is decreased by the viral proofreading exonuclease NSP14-NSP10
Mario Milani et al.
Antiviral research, 189, 105055-105055 (2021-03-14)
The current emergency of the novel coronavirus SARS-CoV2 urged the need for broad-spectrum antiviral drugs as the first line of treatment. Coronaviruses are a large family of viruses that already challenged humanity in at least two other previous outbreaks and
Daniel Poston et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(5), e1208-e1211 (2020-12-04)
Cross-reactive immune responses elicited by seasonal coronaviruses might affect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) susceptibility and disease outcomes. We measured neutralizing activity against SARS-CoV-2 in prepandemic sera from patients with prior polymerase chain reaction scan-confirmed seasonal coronavirus infection.
Jang-Hoon Choi et al.
PloS one, 15(5), e0232757-e0232757 (2020-05-10)
Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory infection and continues to infect humans, thereby contributing to a high mortality rate (34.3% in 2019). In the absence of an available licensed vaccine and antiviral agent, therapeutic human antibodies have
Kentaro Uemura et al.
iScience, 24(10), 103120-103120 (2021-09-21)
Newly emerging or re-emerging viral infections continue to cause significant morbidity and mortality every year worldwide, resulting in serious effects on both health and the global economy. Despite significant drug discovery research against dengue viruses (DENVs) and severe acute respiratory
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门